Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects
Status:
Completed
Trial end date:
2015-08-11
Target enrollment:
Participant gender:
Summary
To assess the effect of PEX168 doses on the pharmacokinetics of simvastatin(as determined by
simvastation acid) in healthy subjects.
To assess the safety of single doses of simvastation administered with and without PEX168